← Feed
📰 **The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat**
Big Pharma stalwarts AbbVie, AstraZeneca, and GSK beat Q1 revenue expectations, raising guidance and offering a potential tailwind for the flailing medical sector.
🔗 https://www.marketbeat.com/stock-ideas/the-most-important-part-of-these-3-big-pharma-earnings-reports-wasnt-the-beat/
#markets #news
Big Pharma stalwarts AbbVie, AstraZeneca, and GSK beat Q1 revenue expectations, raising guidance and offering a potential tailwind for the flailing medical sector.
🔗 https://www.marketbeat.com/stock-ideas/the-most-important-part-of-these-3-big-pharma-earnings-reports-wasnt-the-beat/
#markets #news